1.1 billion India-made Covid vaccine doses under new COVAX scheme supply deal

New Delhi - UNICEF chief said the shots would be delivered over a number of years for low and middle-income countries.

By Reuters

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Wed 3 Feb 2021, 5:54 PM

Last updated: Wed 3 Feb 2021, 6:01 PM

India's Serum Institute will supply 1.1 billion doses of Covid-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of the UN Children's Fund said on Wednesday.

UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.


They would be produced by Serum under a technology transfer agreement, she said in a briefing.

The COVAX facility is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and UNICEF.


Top Stories


More news from